HOLLAND & KNIGHT LLP

Lobbying for SOUND PHARMACEUTICALS, INC. · Bio-pharmaceutical platform developing novel treatments to prevent and treat hearing loss

Filing 1st Quarter - Report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Income

$10,000.00

What the client paid this registrant for the period.

Client based in

Washington

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 4

Budget/Appropriations

Issues related to hearing loss and treatment.

Medical/Disease Research/Clinical Labs

Issues related to hearing loss and treatment.

Defense

Issues related to hearing loss and treatment.

Veterans

Issues related to hearing loss and treatment.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.